Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Aug;155(2):374-382.e1.
doi: 10.1053/j.gastro.2018.04.016. Epub 2018 Apr 22.

Prevalence of Celiac Disease in Patients With Iron Deficiency Anemia-A Systematic Review With Meta-analysis

Affiliations
Meta-Analysis

Prevalence of Celiac Disease in Patients With Iron Deficiency Anemia-A Systematic Review With Meta-analysis

Srihari Mahadev et al. Gastroenterology. 2018 Aug.

Abstract

Background & aims: Anemia is common in patients with celiac disease (CD) and a frequent mode of presentation. Guidelines recommend screening patients with iron-deficiency anemia (IDA) for CD. However, the reported prevalence of CD in patients with IDA varies. We performed a systematic review to determine the prevalence of biopsy-verified CD in patients with IDA.

Methods: We performed a systematic review of articles published in PubMed Medline or EMBASE through July 2017 for the term "celiac disease" combined with "anemia" or "iron deficiency." We used fixed-effects inverse variance-weighted models to measure the pooled prevalence of CD. Meta-regression was used to assess subgroup heterogeneity.

Results: We identified 18 studies composed of 2998 patients with IDA for inclusion in our analysis. Studies originated from the United Kingdom, United States, Italy, Turkey, Iran, and Israel. The crude unweighted prevalence of CD was 4.8% (n = 143). Using a weighted pooled analysis, we found a prevalence of biopsy-confirmed CD of 3.2% (95% confidence interval = 2.6-3.9) in patients with IDA. However, heterogeneity was high (I2 = 67.7%). The prevalence of CD was not significantly higher in studies with a mean participant age older or younger than 18 years or in studies with a mixed-sex vs female-predominant (≥60%) population. On meta-regression, year of publication, female proportion, age at CD testing, and prevalence in the general population were not associated with the prevalence of CD in patients with IDA. In the 8 studies fulfilling all our quality criteria, the pooled prevalence of CD was 5.5% (95% confidence interval = 4.1-6.9).

Conclusions: In a systematic review and meta-analysis, we found that approximately 1 in 31 patients with IDA have histologic evidence of CD. This prevalence value justifies the practice of testing patients with IDA for CD.

Keywords: Celiac; Coeliac; Iron Deficiency; Meta-Analysis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Prevalence of biopsy-verified celiac disease in iron-deficiency anemia
Figure 2
Figure 2
a. Meta-regression: Relationship between age at CD investigation and CD prevalence in iron-deficiency anemia. Y-axis: Percentage (%) of celiac disease among patients with iron-deficiency anemia among. X-axis: Age in years when tested for CD (p=0.461). Age represents median age for the following three studies, , and otherwise mean age. b. Meta-regression: Relationship between proportion of women and CD prevalence in iron-deficiency anemia. Y-axis: Percentage (%) of celiac disease among study participants with iron-deficiency anemia.X-axis: Percentage of females in each individual study (p=0.726). c. Meta-regression: Relationship between year of publication and CD prevalence in iron-deficiency anemia. Y-axis: Percentage (%) of celiac disease among study participants with iron-deficiency anemia. X-axis: Year of study publication (p=0.377). d. Meta-regression: Relationship between CD prevalence in the general population and CD prevalence in iron-deficiency anemia. Y-axis: Percentage (%) of celiac disease among study participants with iron-deficiency anemia. X-axis: Prevalence of CD in the general population (p=0.829).

References

    1. Lebwohl B, Ludvigsson JF, Green PH. Celiac disease and non-celiac gluten sensitivity. BMJ. 2015;351:h4347. - PMC - PubMed
    1. Liu E, Lee HS, Aronsson CA, et al. Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med. 2014;371:42–9. - PMC - PubMed
    1. Kuja-Halkola R, Lebwohl B, Halfvarson J, et al. Heritability of non-HLA genetics in coeliac disease: a population-based study in 107 000 twins. Gut. 2016;65:1793–1798. - PubMed
    1. Tio M, Cox MR, Eslick GD. Meta-analysis: coeliac disease and the risk of all-cause mortality, any malignancy and lymphoid malignancy. Aliment Pharmacol Ther. 2012;35:540–51. - PubMed
    1. Elfstrom P, Sundstrom J, Ludvigsson JF. Systematic review with meta-analysis: associations between coeliac disease and type 1 diabetes. Aliment Pharmacol Ther. 2014;40:1123–32. - PubMed

Publication types